Back to ALLIANCEBERNSTEIN L.P. ALLIANCEBERNSTEIN L.P.

DNTHDNTH
9 quarters

Position history for ALLIANCEBERNSTEIN L.P.ALLIANCEBERNSTEIN L.P.'s holdings in Dianthus Therapeutics, Inc.

ALLIANCEBERNSTEIN L.P. holds 834,150 shares of DNTH (Dianthus Therapeutics, Inc.), worth $70M as of 2026-Q2. The position was decreased (-9.9% shares). DNTH represents 0.0% of ALLIANCEBERNSTEIN L.P.'s portfolio.

Current Value

$70M

Current Shares

834,150

Total Value Change

+$69.4M

Total Shares Change

+809,140

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
834,150
-9.9%
$70M0.0%$97.48
0
2026-Q1
Increased
926,071
+11.0%
$38.2M0.0%$55.39
32
2025-Q4
Decreased
834,383
-2.1%
$34.4M0.0%$40.96
0
2025-Q3
Decreased
852,384
-27.4%
$33.5M0.0%$39.55
0
2025-Q2
Increased
1.2M
+14.6%
$21.9M0.0%$17.63
33
2025-Q1
Decreased
1M
-11.6%
$18.6M0.0%$19.99
0
2024-Q4
Increased
1.2M
+13.3%
$25.3M0.0%$21.50
32
2024-Q3
Increased
1M
+3990.9%
$28M0.0%$27.24
46
2024-Q2
New
25,010
-
$647,2590.0%$25.88
34

Other major holders of DNTH: FMR LLC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used